Wait for it. Wait for it. That’s what the world has been doing ever since 1984 with the “it” being an effective and safe HIV vaccine. That year Margaret Heckler, then the U.S. Secretary of Health and Human Services, said in a press conference, “we hope to have a vaccine ready for testing in about two years,” and added, “"yet another terrible disease is about to yield to patience, persistence and outright genius.” Those words offered some encouragement that an HIV vaccine could have been available for use before the end of the 1980’s. Well, that prediction turned out to be off by oh about 30 years and counting. But after years of “wait for it,” there is optimism that the legendary arrival of a real HIV vaccine could happen as soon as 2021.
- November 07, 2018
Despite many years of enthusiastic calls for an “end to AIDS,” experts have yet to settle on what that would actually entail.
- April 30, 2018
A truly dismal flu vaccine could still save thousands of lives, as long as roughly 40 percent of Americans got their shots, new research suggests.
- April 18, 2018
Approximately 99% of prenatal Zika infections could be avoided through immunization with a vaccine that demonstrates 75% efficacy, according to findings published in the Annals of Internal Medicine.
- April 11, 2018
A Zika vaccine could have a substantial effect on mitigating and preventing future Zika virus outbreaks. Through a combination of direct protection and indirect reduction of transmissions, virtual elimination is achievable, even with imperfect vaccine efficacy and coverage, a new Yale School of Public Health study finds.
- June 29, 2017
In the preamble of the United States Constitution, a primary goal of government was established: “to promote the general Welfare”. Upon the opening of budget deliberations for the 115th US Congressional session, we suggest an evidence-based approach for the new Congress in aligning the budget process more closely with this national goal. In particular, we underscore the efficiency of the US public health sector in promoting societal welfare, and reveal a relative underinvestment in public health compared with other sectors.
- June 09, 2017
The White House budget, in both its 16 March and 23 May iterations, calls for substantial cuts to science and research. The Fogarty International Center of the National Institutes of Health is one of the many programs on the chopping block. Closing Fogarty, which has served as the cornerstone of the American strategy to promote global health, would be a mistake.
- May 15, 2017
The Zika virus, which continues to grow internationally, has the potential to cause widespread harm not only the health of people in affected areas, but to local economies as well.
- April 10, 2017
Though there have been extraordinary advances in HIV/AIDS treatment in the past several years, the disease remains a serious health concern worldwide. Promising developments in HIV vaccines are occurring all the time, but their potential long-term impact is still unknown. Using a novel mathematical model, a team at the Yale School of Public Health predicts that vaccines used in concert with other interventions have the potential to avert several million cases of the disease in the coming years.
- February 21, 2017
Six Yale School of Medicine researchers have been elected to the prestigious Connecticut Academy of Science and Engineering (CASE), including: Alison P. Galvani, Jonathon Howard, Ann Kurth, Frederick J. Sigworth, Hugh S. Taylor, and Sandra Wolin.